Ember LifeSciences Expands Series A to $27 Million with Amgen Ventures and TDF Ventures

May 27, 2026
Ember LifeSciences has added new strategic investments from Amgen Ventures and TDF Ventures, bringing its Series A funding total to $27 million. The company also announced the commercial launch of the Ember Cube 2, a reusable cold chain shipping solution with real-time monitoring and cloud tracking.

Ember LifeSciences has received new strategic investments from Amgen Ventures, the corporate venture arm of Amgen, and TDF Ventures, announced in a press release. The new backing raises Ember's total Series A funding to $27 million, following an earlier round led by Sea Court Capital.

The funding coincides with the full commercial release of the Ember Cube 2, a reusable and modular cold chain shipping solution designed for temperature sensitive pharmaceuticals. The system offers real time monitoring and cloud based tracking to improve control and visibility across logistics operations.

Ember LifeSciences, a spinout from Ember Technologies, focuses on temperature control technology for medicine and vaccine transport. The Ember Cube 2 was recently recognized with the Red Dot Award for product design, while the original Ember Cube was named a 2024 TIME Magazine Invention of the Year and a Fast Company World Changing Idea.

Existing customers and investors include CVS Health, Cardinal Health, Chartwell, and USADA. Financial details of the latest investments were not disclosed.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Funding News AI Brief AI Brief (X)

More from: Life Sciences

05/27
Merck KGaA Selects Veeva Vault CRM for Global Use
05/27
Subtle Medical Receives FDA Clearance for SubtleHD PET Imaging Software
05/27
Chinese Study Tests AI Assisted Ultrasound for Detecting Carotid Artery Plaque
05/27
L.E.K. Consulting Survey Shows Growing Financial Divide Among U.S. Health Systems
05/27
Debut and Natura Partner on AI Discovered Skin Longevity Ingredient for Latin America

More from: Funding

05/27
ElevenLabs Unveils Music v2 Model with Genre Switching and Section Editing
05/27
Xactus Acquires Mortgage Credit Link from MeridianLink and Launches XedaLink Brand
05/27
Slamcore Raises $14 Million to Expand Visual AI for Industrial Fleets
05/27
Sychedelic Raises $3.5 Million to Launch Neurostimulation Headphones
05/27
FORT Robotics Acquires Mapless AI to Add Remote Supervision and Active Safety

Subscribe to AI Funding Brief

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like